Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01296620 · ClinicalTrials.gov registry record · Phase 3
Ulimorelin Study of Efficacy and Safety (ULISES 008)
A Phase 3 study, sponsored by Tranzyme.
- Completed
- Registry status
- Phase 3
- Development phase
- 330
- Enrollment target
NCT01296620: Completed Phase 3 study, sponsored by Tranzyme.
NCT01296620 is a Phase 3 study that has completed, run by Tranzyme. The registered enrollment target is 330 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01296620, a Phase 3 study, has completed, sponsored by Tranzyme.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 330 participants
- Enrollment target
Study Summary
Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection
Interventions
- DRUG Ulimorelin Intravenously (IV)
- DRUG 5% dextrose in water
- DRUG Ulimorelin Invtravenously (IV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
What the finished NCT01296620 record still lists
NCT01296620 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 3 interventions - of which Ulimorelin Intravenously (IV) is the first listed.
NCT01296620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01296620 about?
NCT01296620 is a clinical study titled "Ulimorelin Study of Efficacy and Safety (ULISES 008)". Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection
What is the current status of trial NCT01296620?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 330 participants. The study started on 2011-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01296620?
The interventions under investigation include: Ulimorelin Intravenously (IV) (DRUG), 5% dextrose in water (DRUG), Ulimorelin Invtravenously (IV) (DRUG).
Who is sponsoring clinical trial NCT01296620?
This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01296620's enrollment target sits among peer trials
330 1066th of 2000 higher than 927 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia